Upregulation of Ski in fibroblast is implicated in the peroxisome proliferator-activated receptor δ-mediated wound healing

Cellular Physiology and Biochemistry

Volumn 30, Issue 4, 2012, Pages 1059-1071

  Li, Jun ^a   Li, Ping ^a   Zhang, Yan ^a   Li, Gong Bo ^a   He, Feng Tian ^a   Zhou, Yuan Guo ^a   Yang, Kang ^a   Dai, Shuang Shuang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Fibroblast; PPAR ; Ski; Wound healing

Indexed keywords

CELL PROTEIN; LUCIFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; SKI PROTEIN; UNCLASSIFIED DRUG; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; FEMALE; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENE; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UPREGULATION; WESTERN BLOTTING; WOUND HEALING;

RATTUS;

EID: 84867216332     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000341482     Document Type: Article

References (52)

1. Coulombe PA: Wound epithelialization: accelerating the pace of discovery. J Invest Dermatol 2003;121:219-230.
2. Werner S, Grose R: Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003;83:835-870. (Pubitemid 36828927)
3. Li Y, Turck CM, Teumer JK, Stavnezer E: Unique sequence, ski, in Sloan-Kettering avian retroviruses with properties of a new cell-derived oncogene. J Virol 1986;57:1065-1072. (Pubitemid 16143990)
4. Deheuninck J, Luo K: Ski and SnoN, potent negative regulators of TGF-beta signaling. Cell Res 2009;19:47-57.
5. Akiyoshi S, Inoue H, Hanai J, Kusanagi K, Nemoto N, Miyazono K, Kawabata M: c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. J Biol Chem 1999;274:35269-35277. (Pubitemid 129509586)
6. Bonnon C, Atanasoski S: c-Ski in health and disease. Cell Tissue Res 2012;347:51-64.
7. Baranek C, Dittrich M, Parthasarathy S, Bonnon CG, Britanova O, Lanshakov D, Boukhtouche F, Sommer JE, Colmenares C, Tarabykin V, Atanasoski S: Protooncogene Ski cooperates with the chromatin-remodeling factor Satb2 in specifying callosal neurons. Proc Natl Acad Sci U S A 2012;109:3546-3551.
8. Diaz M, Martel N, Fitzsimmons RL, Eriksson NA, Cowin G, Thomas G, Le Cao KA, Muscat GE, Leong GM: Ski overexpression in skeletal muscle modulates genetic programs that control susceptibility to diet-induced obesity and insulin signaling. Obesity (Silver Spring) 2012; DOI: oby2012101 [pii] 10.1038/oby.2012.101.
9. Kiyono K, Suzuki HI, Morishita Y, Komuro A, Iwata C, Yashiro M, Hirakawa K, Kano MR, Miyazono K: c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma. Cancer Sci 2009;100:1809-1816.
10. Li P, Liu P, Xiong RP, Chen XY, Zhao Y, Lu WP, Liu X, Ning YL, Yang N, Zhou YG: Ski, a modulator of wound healing and scar formation in the rat skin and rabbit ear. J Pathol 2011;223:659-671.
11. Liu X, Li P, Liu P, Xiong R, Zhang E, Chen X, Gu D, Zhao Y, Wang Z, Zhou Y: The essential role for c-Ski in mediating TGF-beta1-induced bi-directional effects on skin fibroblast proliferation through a feedback loop. Biochem J 2008;409:289-297.
12. Liu X, Zhang E, Li P, Liu J, Zhou P, Gu DY, Chen X, Cheng T, Zhou Y: Expression and possible mechanism of cski, a novel tissue repair-related gene during normal and radiation-impaired wound healing. Wound Repair Regen 2006;14:162-171.
13. Novac N, Heinzel T: Nuclear receptors: overview and classification. Curr Drug Targets Inflamm Allergy 2004;3:335-346. (Pubitemid 39534770)
14. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 1988;240:889-895.
15. Warnmark A, Treuter E, Wright AP, Gustafsson JA: Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Mol Endocrinol 2003;17:1901-1909. (Pubitemid 37287610)
16. Desvergne B, Ijpenberg A, Devchand PR, Wahli W: The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling. J Steroid Biochem Mol Biol 1998;65:65-74. (Pubitemid 28335592)
17. Desvergne B, Wahli W: Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999;20:649-688. (Pubitemid 30650602)
18. Kersten S, Desvergne B, Wahli W: Roles of PPARs in health and disease. Nature 2000;405:421-424. (Pubitemid 30367411)
19. Lazennec G, Canaple L, Saugy D, Wahli W: Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol Endocrinol 2000;14:1962-1975. (Pubitemid 32055530)
20. Tugwood JD, Issemann I, Anderson RG, Bundell KR, McPheat WL, Green S: The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene. EMBO J 1992;11:433-439.
21. Tan NS, Michalik L, Di-Poi N, Desvergne B, Wahli W: Critical roles of the nuclear receptor PPARbeta (peroxisome-proliferator-activated receptor beta) in skin wound healing. Biochem Soc Trans 2004;32:97-102. (Pubitemid 38283023)
22. Tan NS, Michalik L, Desvergne B, Wahli W: Peroxisome proliferator- activated receptor-beta as a target for wound healing drugs. Expert Opin Ther Targets 2004;8:39-48. (Pubitemid 38240023)
23. Tan NS, Michalik L, Desvergne B, Wahli W: Peroxisome proliferator- activated receptor (PPAR)-beta as a target for wound healing drugs: what is possible? Am J Clin Dermatol 2003;4:523-530. (Pubitemid 36995073)
24. Ham SA, Kim HJ, Kang ES, Eun SY, Kim GH, Park MH, Woo IS, Chang KC, Lee JH, Seo HG: PPARdelta promotes wound healing by up-regulating TGF-beta1-dependent or -independent expression of extracellular matrix proteins. J Cell Mol Med 2010;14:1747-1759.
25. Zargarova T, Kulakova O, Prassolov V, Zharmukhamedova T, Tsyganova V, Turobov V, Ivanov D, Parfenov M, Sudomoina M, Chernajovsky Y, Favorova O: Prevention of experimental autoimmune encephalomyelitis in DA rats by grafting primary skin fibroblasts engineered to express transforming growth factor-beta1. Clin Exp Immunol 2004;137:313-319. (Pubitemid 39013077)
26. Liu X, Liu JZ, Zhang E, Li P, Zhou P, Cheng TM, Zhou YG: Impaired wound healing after local soft x-ray irradiation in rat skin: time course study of pathology, proliferation, cell cycle, and apoptosis. J Trauma 2005;59:682-690. (Pubitemid 43014936)
27. Chao F, Gong W, Zheng Y, Li Y, Huang G, Gao M, Li J, Kuruba R, Gao X, Li S, He F: Upregulation of scavenger receptor class B type I expression by activation of FXR in hepatocyte. Atherosclerosis 2010;213:443-448.
28. Takasu H, Sugita A, Uchiyama Y, Katagiri N, Okazaki M, Ogata E, Ikeda K: c-Fos protein as a target of antiosteoclastogenic action of vitamin D, and synthesis of new analogs. J Clin Invest 2006;116:528-535. (Pubitemid 43228371)
29. Li Y, Yin W, Wang X, Zhu W, Huang Y, Yan G: Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway. Proc Natl Acad Sci U S A 2007;104:13438-13443. (Pubitemid 47293963)
30. Montagner A, Rando G, Degueurce G, Leuenberger N, Michalik L, Wahli W: New insights into the role of PPARs. Prostaglandins Leukot Essent Fatty Acids 2011;85:235-243.
31. Kilgore KS, Billin AN: PPARbeta/delta ligands as modulators of the inflammatory response. Curr Opin Investig Drugs 2008;9:463-469. (Pubitemid 351677899)
32. Short B: Time (and PPAR beta/delta) heals all wounds. J Cell Biol 2009;184:767.
33. Wahli W: Peroxisome proliferator-activated receptors (PPARs): from metabolic control to epidermal wound healing. Swiss Med Wkly 2002;132:83-91. (Pubitemid 34492280)
34. Chong HC, Tan MJ, Philippe V, Tan SH, Tan CK, Ku CW, Goh YY, Wahli W, Michalik L, Tan NS: Regulation of epithelial-mesenchymal IL-1 signaling by PPARbeta/delta is essential for skin homeostasis and wound healing. J Cell Biol 2009;184:817-831.
35. Tan NS, Michalik L, Noy N, Yasmin R, Pacot C, Heim M, Fluhmann B, Desvergne B, Wahli W: Critical roles of PPAR beta/delta in keratinocyte response to inflammation. Genes Dev 2001;15:3263-3277. (Pubitemid 34008192)
36. Singer AJ, Clark RA: Cutaneous wound healing. N Engl J Med 1999;341:738-746. (Pubitemid 29407375)
37. Zajicek R, Mandys V, Mestak O, Sevcik J, Konigova R, Matouskova E: Human Keratinocyte Growth and Differentiation on Acellular Porcine Dermal Matrix in relation to Wound Healing Potential. Scientific World Journal 2012;2012:727352.
38. Miao M, Niu Y, Xie T, Yuan B, Qing C, Lu S: Diabetes-impaired wound healing and altered macrophage activation: a possible pathophysiologic correlation. Wound Repair Regen 2012;20:203-213.
39. Parsonage G, Filer AD, Haworth O, Nash GB, Rainger GE, Salmon M, Buckley CD: A stromal address code defined by fibroblasts. Trends Immunol 2005;26:150-156. (Pubitemid 40312522)
40. Tan NS, Michalik L, Di-Poi N, Ng CY, Mermod N, Roberts AB, Desvergne B, Wahli W: Essential role of Smad3 in the inhibition of inflammation-induced PPARbeta/delta expression. EMBO J 2004;23:4211-4221. (Pubitemid 39546159)
41. Mustoe TA, Pierce GF, Thomason A, Gramates P, Sporn MB, Deuel TF: Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science 1987;237:1333-1336. (Pubitemid 17125439)
42. Puolakkainen PA, Reed MJ, Gombotz WR, Twardzik DR, Abrass IB, Sage HE: Acceleration of wound healing in aged rats by topical application of transforming growth factor-beta (1). Wound Repair Regen 1995;3:330-339.
43. Koch RM, Roche NS, Parks WT, Ashcroft GS, Letterio JJ, Roberts AB: Incisional wound healing in transforming growth factor-beta1 null mice. Wound Repair Regen 2000;8:179-191. (Pubitemid 30421521)
44. Crowe MJ, Doetschman T, Greenhalgh DG: Delayed wound healing in immunodeficient TGF-beta 1 knockout mice. J Invest Dermatol 2000;115:3-11. (Pubitemid 30470184)
45. Kim HJ, Ham SA, Kim SU, Hwang JY, Kim JH, Chang KC, Yabe-Nishimura C, Seo HG: Transforming growth factor-beta1 is a molecular target for the peroxisome proliferator-activated receptor delta. Circ Res 2008;102:193-200. (Pubitemid 351651123)
46. Tan NS, Michalik L, Desvergne B, Wahli W: Genetic-or transforming growth factor-beta 1-induced changes in epidermal peroxisome proliferator-activated receptor beta/delta expression dictate wound repair kinetics. J Biol Chem 2005;280:18163-18170. (Pubitemid 41389061)
47. Fukuchi M, Nakajima M, Fukai Y, Miyazaki T, Masuda N, Sohda M, Manda R, Tsukada K, Kato H, Kuwano H: Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma. Int J Cancer 2004;108:818-824. (Pubitemid 38112608)
48. Javelaud D, Van Kempen L, Alexaki VI, Le Scolan E, Luo K, Mauviel A: Efficient TGF-beta/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression. Mol Cancer 2011;10:2.
49. Carbo N, Costelli P, Busquets S, Lopez-Soriano J, Lopez-Soriano FJ, Baccino FM, Argiles JM: Effect of c-ski overexpression on the development of cachexia in mice bearing the Lewis lung carcinoma. Int J Mol Med 2004;14:719-723.
50. Jaeckel EC, Raja S, Tan J, Das SK, Dey SK, Girod DA, Tsue TT, Sanford TR: Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2001;127:1253-1259. (Pubitemid 32947457)
51. Tong BJ, Tan J, Tajeda L, Das SK, Chapman JA, Du Bois RN, Dey SK: Heightened expression of cyclooxygenase-2. and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma. Neoplasia 2000;2:483-490. (Pubitemid 32098682)
52. Peters JM, Lee SS, Li W, Ward JM, Gavrilova O, Everett C, Reitman ML, Hudson LD, Gonzalez FJ: Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta (delta). Mol Cell Biol 2000;20:5119-5128. (Pubitemid 30431565)